Trademark: 79251242
Word
DBV TECHNOLOGIES
Status Date
Tuesday, July 23, 2019
Registration Number
5809654
Registration Date
Tuesday, July 23, 2019
Filing Date
Tuesday, November 6, 2018
Published for Opposition
Tuesday, May 7, 2019
5 adhesive patches enabling cutaneous or epicutaneous administration of powdered medicated or pharmaceutical substances for humans or animals featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases; drug delivery patch containing a preparation in powder form for medical use for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusive patch enabling the cutaneous absorption of a powdered medicated substance featuring pharmaceutical preparations for treatment of allergies, inflammatory and autoimmune diseases
44 medical services applying a method for desensitizing by immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergies, inflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies
10 medical apparatus, instruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animals, namely, drug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible support, namely epicutaneous patches sold without medication
42 research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin, other than simple and light cleaning in order to leave the cell structure of the skin intact, thus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact
The mark consists of the wording a "DBV TECHNOLOGIES" in black and a design comprised of two gray concentric circles above a cyan curved line. White is not claimed as a feature of the mark and represents background or transparent areas, only.
The color(s) gray, cyan, and black is/are claimed as a feature of the mark.
"TECHNOLOGIES"
Feb 20, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Feb 7, 2019
Sn Assigned For Sect 66a Appl From Ib
Feb 11, 2019
New Application Office Supplied Data Entered
Feb 11, 2019
Assigned To Examiner
Feb 15, 2019
Application Filing Receipt Mailed
Feb 19, 2019
Non-Final Action Written
Feb 28, 2019
Refusal Processed By Mpu
Feb 28, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Mar 14, 2019
Teas Response To Office Action Received
Mar 14, 2019
Correspondence Received In Law Office
Mar 14, 2019
Teas/Email Correspondence Entered
Mar 15, 2019
Approved For Pub - Principal Register
Mar 16, 2019
Refusal Processed By Ib
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
May 7, 2019
Published For Opposition
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Registered-Principal Register
Jun 15, 2024
New Representative At Ib Received
Nov 1, 2021
New Representative At Ib Received
Oct 23, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 15, 2019
Final Disposition Processed
Nov 15, 2019
Final Disposition Notice Sent To Ib
Dec 6, 2019
Final Decision Transaction Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
